ARTICLE | Clinical News
BRCA1 and BRCA2 breast and ovarian cancer genes regulatory update
May 21, 2001 7:00 AM UTC
Myriad Genetics Inc. (MYGN), Salt Lake City, Utah Product: BRCA1 and BRCA2 breast and ovarian cancer genes Business: Pharmacogenetics MYGN received eight patents covering the use of BRCA1 and BRCA2 ...